Literature DB >> 16231268

The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.

N Kumarasamy1, Suniti Solomon, Sreekanth K Chaguturu, Anitha J Cecelia, Snigdha Vallabhaneni, Timothy P Flanigan, Kenneth H Mayer.   

Abstract

The number of individuals seeking treatment for infection with human immunodeficiency virus increased as the cost of highly active antiretroviral therapy (HAART) decreased 20-fold after the introduction of generic HAART in India in the year 2000. The incidence of tuberculosis and opportunistic infections decreased to <2 cases per 100 person-years. Death rates decreased from 25 to 5 deaths per 100 person-years between 1997 and 2003.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16231268     DOI： 10.1086/497267

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  43 in total

1.  Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania.

Authors:  Daudi R Mavura; E John Masenga; Eli Minja; Henning Grossmann; John A Crump; John A Bartlett
Journal:  Int J Dermatol       Date:  2014-09-26       Impact factor: 2.736

2.  Gender-based differences in treatment and outcome among HIV patients in South India.

Authors:  N Kumarasamy; K K Venkatesh; A J Cecelia; B Devaleenol; S Saghayam; T Yepthomi; P Balakrishnan; T Flanigan; S Solomon; K H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2008-11       Impact factor: 2.681

3.  Spectrum of malignancies among HIV-infected patients in South India.

Authors:  K K Venkatesh; S Saghayam; B Devaleenal; S Poongulali; T P Flanigan; K H Mayer; N Kumarasamy
Journal:  Indian J Cancer       Date:  2012 Jan-Mar       Impact factor: 1.224

4.  Pharmacokinetics of lamivudine & stavudine in generic fixed-dose combinations in HIV-1 infected adults in India.

Authors:  A K Hemanth Kumar; Geetha Ramachandran; S Rajasekaran; C Padmapriyadarsini; G Narendran; S Anitha; Sudha Subramanyam; V Kumaraswami; Soumya Swaminathan
Journal:  Indian J Med Res       Date:  2009-10       Impact factor: 2.375

5.  Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.

Authors:  S Saravanan; M Vidya; P Balakrishnan; P Balakrishanan; N Kumarasamy; Sunil S Solomon; S Solomon; Rami Kantor; David Katzenstein; Bharat Ramratnam; Kenneth H Mayer
Journal:  J Virol Methods       Date:  2009-04-02       Impact factor: 2.014

6.  Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India.

Authors:  Sanjay Pujari; Ameet Dravid; Nikhil Gupte; Kedar Joshi; Vivek Bele
Journal:  Medscape J Med       Date:  2008-08-20

7.  Social, Psychological and Health Concerns of People Living with HIV/AIDS in Mysore District, Karnataka.

Authors:  Shibu Thomas Sebastian; Sunitha Siddanna
Journal:  J Clin Diagn Res       Date:  2016-03-01

8.  Prevalence and incidence of sexually transmitted infections among South Indians at increased risk of HIV infection.

Authors:  N Kumarasamy; P Balakrishnan; K K Venkatesh; A K Srikrishnan; A J Cecelia; E Thamburaj; S Solomon; K H Mayer
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

9.  Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India.

Authors:  Sanjay Pujari; Ameet Dravid; Nikhil Gupte; Kedar Joshix; Vivek Bele
Journal:  J Int AIDS Soc       Date:  2008-08-20       Impact factor: 5.396

10.  Can we spend our way out of the AIDS epidemic? A world halting AIDS model.

Authors:  Robert J Smith; Jing Li; Richard Gordon; Jane M Heffernan
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.